Hemodynamic Effects of Interfacility Dexmedetomidine Infusions During Transport of Patients with Alpha-2-adrenergic Agonist Withdrawal
Scott Goldstein, Nathaniel Zahustecher, Derek Isenberg, Eric Rosen, Celine Bennett · 2026
Read Hemodynamic Effects of Interfacility Dexmedetomidine Infusions During Transport of Patients with Alpha-2-adrenergic Agonist Withdrawal by Scott Goldstein, Nathaniel Zahustecher, Derek Isenberg, Eric Rosen, Celine Bennett (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13660583.txt.
Description
Goldstein and four co-authors study a sedation drug used during patient transport, in work from twenty twenty-six. In the Philadelphia area, street opioids now often hold medetomidine, a vet sedative. Withdrawal from it can be life threatening, unlike plain opioid withdrawal.
Dexmedetomidine, a related drug, is used off label to treat that withdrawal. The study describes its dosing and effects on blood pressure and heart rate when given while patients move between facilities. Transport is a risky window with less monitoring than a hospital unit. Clear data on dose and heart effects can help transport teams use the drug more safely.
Catalog record
| CREATOR | Scott Goldstein, Nathaniel Zahustecher, Derek Isenberg, Eric Rosen, Celine Bennett |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 12 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |